# DANZITEN

NDC: 24338-155
Generic name: nilotinib
Labeler / Manufacturer: Azurity Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20241130

FDA application: NDA219293

## Active ingredients

- NILOTINIB: 95 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24338-155"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24338-155
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d288d165-3505-49bb-9b2e-124490d65f49